Join Growin Stock Community!
Beta
Back to LLY.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • P/E Ratio
  • P/S Ratio
  • P/B Ratio
  • EV/EBITDA
  • EV/Sales
  • PE Ratio River
pe-stream-chart

LLY PE Ratio River

PE Ratio River

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

## LLY PE Stream Chart Analysis **Current Valuation (Latest Data Point):** As of the latest month (mid-March 2026), LLY's monthly average price stands at approximately **$918.05**, which places it firmly within the **Value Interval** — trading above the 26.2x PE boundary (priced at ~$603.56) but well below the 46.1x PE boundary (priced at ~$1,059.46). This positioning suggests the stock is currently in a relatively **undervalued-to-fair** zone by historical standards, sitting closer to the lower end of its PE band spectrum. The stock would need to appreciate to roughly $1,059 to reach the 46.1x threshold, representing meaningful upside before entering the **Fair Interval** (46.1x–65.9x). **Historical Trend Analysis:** Over the observed period from early 2021 through mid-March 2026, LLY's valuation trajectory has been remarkable and broadly upward-trending, reflecting significant earnings growth that has continuously re-anchored the PE river bands higher. In early 2021, the stock traded near **$180**, comfortably above the 26.2x boundary (~$179) but well below the 46.1x boundary (~$314), placing it in the **Value Interval**. Through 2021 and 2022, the price climbed steadily into the $230–$360 range, consistently remaining within the **Value Interval** as PE boundaries shifted with earnings revisions. A notable inflection occurred in mid-to-late 2023, when the stock surged from ~$320 to over **$570**, briefly approaching and occasionally testing the **Fair Interval** (46.1x–65.9x boundary), as the market began pricing in LLY's GLP-1 drug pipeline momentum. The most dramatic valuation expansion occurred through 2024, when the stock climbed from ~$620 to a peak monthly average near **$906** (around Q3 2024), pushing into the **Fair-to-Watch Interval** territory relative to the then-prevailing PE boundaries. However, a notable correction followed in late 2024 and into 2025, with prices retreating to the $745–$775 range, pulling the stock back toward the **Value Interval**. Encouragingly, a strong recovery emerged in late 2025, with the monthly average surging to over **$1,006–$1,043**, briefly touching the 46.1x boundary (~$944–$1,059), before the most recent data shows a pullback to ~$918. Throughout the entire period, the PE river bands themselves have expanded dramatically — the 26.2x boundary rose from ~$179 in early 2021 to ~$604 by early 2026, and the 46.1x boundary rose from ~$314 to ~$1,059 — confirming sustained and substantial **earnings growth** as the primary driver. Overall, LLY's PE stream chart reflects a company with strong and accelerating profitability, with the stock spending most of its history in the **Value-to-Fair** range, suggesting the market has generally priced it with discipline relative to its earnings power despite the significant price appreciation.